Legend Biotech (LEGN) traded up 5.74 % during a 24 hours period ending at 08:01 AM Central Europe on Wednesday 28th. One Legend Biotech stock can currently be bought for about USD 21.56 on popular exchanges. Current supply of Legend Biotech stocks is 190.1 mn. Legend Biotech has a current market capitalization of USD 3.9 bn and approximately USD 45.7 mn worth of Legend Biotech was traded on exchanges in the last 24 hours. Since last month end, Legend Biotech has traded 15.79 % up. Simple moving average of last 200 days is at USD 22.15. The highest price of past 52 weeks was recorded at USD 37.5 on 06/03/2026. 52 weeks low was at USD 16.24 on 02/04/2026.
Here is how related stocks have performed in the past 24 hours:
Tfs (TFSL) traded up 0.24 % and now trades at USD 16.73. Current market capitalisation for Tfs is USD 4.6 bn. Current price/earnings ratio for Tfs is 46.39.
Griffon (GFF) traded up 2.65 % and now trades at USD 100.26. Current market capitalisation for Griffon is USD 4.5 bn. Current price/earnings ratio for Griffon is 20.4.
Synaptics (SYNA) traded up 0.64 % and now trades at USD 118.1. Current market capitalisation for Synaptics is USD 4.6 bn.
Openlane (OPLN) traded up 1.04 % and now trades at USD 37.83. Current market capitalisation for Openlane is USD 4.6 bn.
Joby Aviation (JOBY) traded up 6.82 % and now trades at USD 5.01. Current market capitalisation for Joby Aviation is USD 4.6 bn.
About Legend Biotech
The Legend Biotech Corporation serves as a biopharmaceutical company, actively involved in uncovering and developing innovative cell therapies for oncology and other health issues. This company, located in Somerset, United States, operates within the Health Care sector, striving to meet the requirements of its New Jersey-based clientele. You can access further information about their activities and offerings through their official website at www.legendbiotech.com , traded on the Nasdaq stock exchange.